[ITCI] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
01-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 30.38%
YoY- 56.55%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 125,810 110,128 94,731 87,433 71,870 55,074 34,755 135.57%
PBT -24,215 -42,649 -44,043 -44,026 -53,507 -86,603 -72,114 -51.65%
Tax 43 135 10 -6,772 1 -2,640 5 319.20%
NP -24,258 -42,784 -44,053 -37,254 -53,508 -83,963 -72,119 -51.60%
Tax Rate - - - - - - - -
Total Cost 150,068 152,912 138,784 124,687 125,378 139,037 106,874 25.36%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -19.28 -38.85 -46.50 -42.61 -74.45 -152.45 -207.51 -79.45%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.25 -0.45 -0.46 -0.39 -0.57 -0.89 -0.78 -53.13%
EPS Diluted -0.25 -0.45 -0.46 -0.39 -0.57 -0.89 -0.78 -53.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.